NM_000102.4(CYP17A1):c.1162A>G (p.Lys388Glu) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 16, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004367762.1

Allele description [Variation Report for NM_000102.4(CYP17A1):c.1162A>G (p.Lys388Glu)]

NM_000102.4(CYP17A1):c.1162A>G (p.Lys388Glu)

Gene:

CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

10q24.32

Genomic location:

Preferred name:

NM_000102.4(CYP17A1):c.1162A>G (p.Lys388Glu)

HGVS:

NC_000010.11:g.102831589T>C
NG_007955.1:g.10945A>G
NM_000102.4:c.1162A>GMANE SELECT
NP_000093.1:p.Lys388Glu
NC_000010.10:g.104591346T>C
NM_000102.3:c.1162A>G

Protein change:

K388E

Molecular consequence:

NM_000102.4:c.1162A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

BioAssay by Target (List) for Gene (Select 135228) (13)
PubChem BioAssay
BioProject Links for Protein (Select 122114649) (2)
BioProject
Related gene-specific medical variations for Gene (Select 135228) (2)
ClinVar
CD109 antigen isoform X1 [Homo sapiens]
CD109 antigen isoform X1 [Homo sapiens]
gi|2462606128|ref|XP_054210277.1|

Protein
RecName: Full=CD109 antigen; AltName: Full=150 kDa TGF-beta-1-binding protein; A...
RecName: Full=CD109 antigen; AltName: Full=150 kDa TGF-beta-1-binding protein; AltName: Full=C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7; AltName: Full=Platelet-specific Gov antigen; AltName: Full=p180; AltName: Full=r150; AltName: CD_antigen=CD109; Flags: Precursor
gi|117949389|sp|Q6YHK3.2|CD109_HUMA

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004854410	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jan 16, 2024)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004854410

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jan 16, 2024)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV004854410.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.1162A>G (p.K388E) alteration is located in exon 7 (coding exon 7) of the CYP17A1 gene. This alteration results from a A to G substitution at nucleotide position 1162, causing the lysine (K) at amino acid position 388 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine